BioXL is an innovative biopharmaceutical company committed to addressing the most pressing and undertreated medical needs through advanced therapeutic solutions.With a focus on scientific excellence and collaboration, BioXL aims to transform healthcare by developing effective therapies that enhance patient outcomes and improve quality of life.Our dedication to innovation and patient-centric approaches drives our mission to empower lives and revolutionize the treatment landscape for underserved populations.Bio-XL has a worldwide exclusive license for the commercialization of the technologies based on intellectual property from Sheba Medical Center in Israel and Cedars-Sinai Medical Center in the U.S.